Coronavirus vaccines leap through safety trials - but which will work is anybody's guess.

Callaway, Ewen

Callaway, Ewen.

Nature ; 583(7818): 669-670, 2020 07.

Article in English | MEDLINE | ID: covidwho-823255

Subject(s)

Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Coronavirus Infections/immunology; Coronavirus Infections/prevention & control; Pandemics/prevention & control; Patient Safety; Pneumonia, Viral/immunology; Pneumonia, Viral/prevention & control; Uncertainty; Viral Vaccines/adverse effects; Viral Vaccines/immunology; Antibodies, Neutralizing/blood; Antibodies, Neutralizing/immunology; Antibodies, Viral/blood; Antibodies, Viral/immunology; Betacoronavirus/immunology; COVID-19; COVID-19 Vaccines; Coronavirus Infections/genetics; Drug Industry; Genetic Vectors; Humans; SARS-CoV-2; T-Lymphocytes/classification; T-Lymphocytes/immunology; Treatment Outcome; Viral Vaccines/genetics

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Viral Vaccines / Clinical Trials, Phase II as Topic / Clinical Trials, Phase I as Topic / Coronavirus Infections / Uncertainty / Pandemics / Patient Safety Type of study: Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Nature Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google